Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences

Rhea-AI Summary

Vanda Pharmaceuticals (Nasdaq: VNDA) will participate in three investor conferences in May 2026: Bank of America Global Health Care (May 12, Las Vegas), HCW BioConnect at Nasdaq (May 19, New York) and B. Riley (May 20, Marina Del Rey).

A fireside chat is scheduled for 2:00 p.m. ET on May 19, 2026 at the HCW BioConnect event; the live stream and an archived recording (available ~30 days) can be accessed via Vanda's investor website. Investors should register on conference sites at least 15 minutes early to install any required software.

News Market Reaction – VNDA

-1.72% 1.7x vol

39 alerts

-1.72% Session close to close

-11.9% Trough in 6 hr 56 min

$447.40M Market Cap

1.7x Rel. Volume

In the May 8 session, VNDA declined 1.72%, reflecting a mild negative market reaction. Argus tracked a trough of -11.9% from its starting point during tracking. Our momentum scanner triggered 39 alerts that day, indicating elevated trading interest and price volatility. Trading volume was above average at 1.7x the daily average, suggesting increased trading activity.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines VNDA’s participation in multiple May 2026 investor conferences, providing...

Analysis

This announcement outlines VNDA’s participation in multiple May 2026 investor conferences, providing additional visibility following recent milestones, including commercial launch of NEREUS™ and pivotal imsidolimab data with a December 12, 2026 FDA action date. Investors may watch how management frames revenue guidance, new product launches, and pipeline progress in these forums. The company also has an effective $200,000,000 shelf registration, so any future capital-raising plans discussed at conferences could be important to monitor.

Key Figures

Conference date: May 12, 2026 Conference date: May 19, 2026 Fireside chat time: 2:00 p.m. Eastern Time +4 more

7 metrics

Conference date May 12, 2026 Bank of America Securities Global Health Care Conference

Conference date May 19, 2026 HCW 4th Annual BioConnect Investor Conference at Nasdaq

Fireside chat time 2:00 p.m. Eastern Time HCW 4th Annual BioConnect Investor Conference

Conference date May 20, 2026 B. Riley Securities 26th Annual Investor Conference

Archive duration 30 days Archived HCW conference fireside chat access on Vanda website

Conference edition 4th Annual HCW BioConnect Investor Conference

Conference edition 26th Annual B. Riley Securities Investor Conference

Historical Context

5 past events · Latest: May 04 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 04	Product launch update	Positive	+8.0%	Announced U.S. commercial availability of NEREUS™ for motion sickness prevention.
May 01	Product launch update	Positive	+8.0%	Detailed U.S. commercial availability and pricing for NEREUS™ motion sickness treatment.
Apr 29	Earnings timing	Neutral	+0.7%	Set date and call details for Q1 2026 financial results release.
Apr 28	Clinical/BLA update	Positive	+3.1%	Reported pivotal Phase III imsidolimab data and BLA with FDA action date.
Apr 22	Board/management change	Positive	-2.0%	Appointed experienced biotech professional Charles Duncan to the Board.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent fundamentally positive updates (NEREUS launch, pivotal data/BLA, earnings-related items) generally saw positive or modestly positive price reactions, with only the board appointment drawing a negative move.

Recent Company History

Over the last few weeks, VNDA has reported several meaningful milestones. U.S. commercial availability of NEREUS™ for motion sickness on May 1 and May 4, 2026 coincided with +8% moves, suggesting constructive reception to the launch. An earnings-date announcement for Q1 2026 on April 29 and publication of pivotal imsidolimab Phase III data with a BLA and December 12, 2026 FDA action date also produced positive reactions. A board expansion and new director appointment on April 22 saw a modest -2.05% decline, indicating governance news has been less favorably received than product and pipeline catalysts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WASHINGTON, May 7, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate at the following upcoming investor conferences in May 2026:

The Bank of America Securities Global Health Care Conference 2026 in Las Vegas, Nevada on Tuesday, May 12, 2026.

The HCW 4^th Annual BioConnect Investor Conference at Nasdaq in New York City on Tuesday, May 19, 2026. A fireside chat is scheduled for 2:00 p.m. Eastern Time.

The B. Riley Securities 26^th Annual Investor Conference in Marina Del Rey, California on Wednesday, May 20, 2026.

The fireside chat given at the HCW 4^th Annual BioConnect Investor Conference at Nasdaq may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-may-2026-investor-conferences-302766347.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

When will Vanda Pharmaceuticals (VNDA) present at the HCW BioConnect conference in May 2026?

Vanda will present at HCW BioConnect on May 19, 2026, with a fireside chat at 2:00 p.m. ET. According to Vanda, the session will be streamed live on the company's investor website and archived for approximately 30 days for later viewing.

How can investors watch the VNDA fireside chat on May 19, 2026?

Investors can watch the VNDA fireside chat live via Vanda's investor website under the Investors tab. According to Vanda, the live link will be available during the HCW BioConnect event and an archived recording will remain accessible for about 30 days.

Which investor conferences will Vanda Pharmaceuticals (VNDA) attend in May 2026?

Vanda will attend three May 2026 conferences: Bank of America Global Health Care (May 12), HCW BioConnect at Nasdaq (May 19), and B. Riley Annual Investor Conference (May 20). According to Vanda, each event includes company presentations or fireside chats for investors.

What should investors do before joining the VNDA webcast at these May 2026 conferences?

Investors should arrive at the conference website at least 15 minutes early to register and install any required software or downloads. According to Vanda, this helps ensure timely access to live presentations and any distributed conference materials.

Will Vanda (VNDA) provide an archive of the May 19, 2026 fireside chat and for how long?

Yes, Vanda will provide an archived recording of the May 19 fireside chat for approximately 30 days on its investor website. According to Vanda, investors can access the archived content via the Recent Events link under the Investors tab.